Characterization of a L136P mutation in Formin-like 2 (FMNL2) from a patient with chronic inflammatory bowel disease

• Raphael Trefzer,

  Roles Conceptualization, Formal analysis, Investigation, Writing – original draft

  Affiliation Institute of Pharmacology, University of Marburg, Marburg, Germany

  https://orcid.org/0000-0003-3687-9830

  ⨯
• Orly Elpeleg,

  Roles Formal analysis, Supervision, Writing – original draft

  Affiliation Department of Genetics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  ⨯
• Tatyana Gabrusskaya,

  Roles Formal analysis, Investigation, Writing – original draft

  Affiliation Department of Gastroenterology, St. Petersburg State Pediatric Medical University, St. Petersburg, Russia

  ⨯
• Polina Stepensky,

  Roles Formal analysis, Investigation, Writing – original draft

  Affiliation Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  ⨯
• Hagar Mor-Shaked,

  Roles Formal analysis, Software

  Affiliation Department of Genetics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  ⨯
• Robert Grosse,

  Roles Funding acquisition, Supervision, Writing – original draft

  Affiliations Institute of Pharmacology, University of Marburg, Marburg, Germany, Institute of Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Freiburg, Germany

  ⨯
• Dominique T. Brandt

  Roles Conceptualization, Formal analysis, Supervision, Writing – original draft

  * E-mail: brandtd@staff.uni-marburg.de

  Affiliation Institute of Pharmacology, University of Marburg, Marburg, Germany

  https://orcid.org/0000-0003-3721-0581

  ⨯